Theravance Biopharma, Inc. (TBPH)
13.57
-0.01
(-0.07%)
USD |
NASDAQ |
Mar 06, 16:00
13.56
-0.01
(-0.07%)
After-Hours: 20:00
Theravance Biopharma SG&A Expense (TTM) : 75.94M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Integer Holdings Corp. | 211.75M |
| QuidelOrtho Corp. | 746.30M |
| Corcept Therapeutics, Inc. | 448.72M |
| Nektar Therapeutics | 74.62M |
| Innoviva, Inc. | 113.32M |